Vitrolife AB (publ) reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was SEK 3,512 million compared to SEK 3,234 million a year ago. Net loss was SEK 3,851 million compared to net income of SEK 394 million a year ago.

Basic loss per share from continuing operations was SEK 28.44 compared to basic earnings per share from continuing operations of SEK 2.91 a year ago.